Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1025
-
Total shares
-
71.5M
-
Shares change
-
-740K
-
Total reported value, excl. options
-
$35.7B
-
Value change
-
-$335M
-
Put/Call ratio
-
1.18
-
Number of buys
-
453
-
Number of sells
-
-456
-
Price
-
$500.08
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q1 2023
1,048 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q1 2023.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,025 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.5M shares
of 80.8M outstanding shares and own 88.45% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.7M shares), VANGUARD GROUP INC (8.2M shares), STATE STREET CORP (3.67M shares), ALLIANCEBERNSTEIN L.P. (3.38M shares), Fundsmith LLP (2.95M shares), BAMCO INC /NY/ (2.36M shares), GEODE CAPITAL MANAGEMENT, LLC (1.95M shares), FRANKLIN RESOURCES INC (1.35M shares), BLAIR WILLIAM & CO/IL (1.21M shares), and Invesco Ltd. (1.19M shares).
This table shows the top 1025 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.